Pharmacy Organizations Establish Pharmacy Workforce Suicide Awareness Day
Drug Topics
SEPTEMBER 20, 2023
Suicides among health care professionals are estimated to occur at a higher rate than in the general public.
Wed.Sep 20, 2023
551 
What happened to ivermectin?
PharmaVoice
SEPTEMBER 20, 2023
The saga of the anti-parasitic drug continues.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Understaffing at CVS Pharmacies in Ohio Lead to Concerns About Patient Safety
Drug Topics
SEPTEMBER 20, 2023
The Ohio Board of Pharmacy found during several inspections that some CVS stores in the state had dirty conditions, a lack of control over dangerous medications, and months-long wait times for medications.
Pharmacy-Led Medication Reconciliation Is Best Practice
Pharmacy Times
SEPTEMBER 20, 2023
The TJC and IHI advocate for medication reconciliation at all transitions of care.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Dupilumab Could Help Improve Lung Function in Young Patients with Asthma
Drug Topics
SEPTEMBER 20, 2023
The phase 3 LIBERTY ASTHMA VOYAGE clinical trial was conducted with the purpose of investigating the effects of the investigational drug and discovering whether it would be a promising option.
Free Covid tests will be offered again to all U.S. households
STAT
SEPTEMBER 20, 2023
The federal government is again offering free Covid-19 tests to Americans, providing a fifth round of free tests in part to meet current needs, in part to stimulate a domestic testing industry that has struggled with cratering demand for the rapid diagnostics. The measure, announced Wednesday, will see rapid tests released from the Strategic National Stockpile.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Does the risk of getting long Covid increase each time you get reinfected?
STAT
SEPTEMBER 20, 2023
More than three years into the coronavirus pandemic, fewer and fewer people are experiencing their first Covid-19 infections. But as cases climb , those who’ve had the virus before may wonder: What are their chances of developing long Covid — and does the risk increase with each reinfection? Fatigue and brain fog may be the first post-infection symptoms that come to mind for long Covid, but lists compiled by the Centers for Disease Control and Prevention and by the World Health Org
Researchers Compare PrEP Treatments for Hypertension Risks
Pharmacy Times
SEPTEMBER 20, 2023
If taking tenofovir alafenamide fumarate, a close monitoring of blood pressure and lipid levels are essential due to greater risk of hypertension.
STAT+: AI is coming to your dentist’s office. Will it build trust, or erode it?
STAT
SEPTEMBER 20, 2023
Open wide, AI wants a look inside your mouth. A new wave of software is promising to supercharge dentists’ ability to spot decay and bone loss — and propose treatments earlier in the disease process. In just the past three years, eight AI products have gained approval from the Food and Drug Administration. Many more are on the way. These tools in some cases identify lesions years before dentists can see them on X-rays and other images, providing increased treatment opportunities ba
Expert: The Medication Use Process in a Health System Is the Foundational Requisite for Safe Use of Medication
Pharmacy Times
SEPTEMBER 20, 2023
Dapo Amosu, MS, PharmD, DPLA, discusses his thoughts on how to advance medication use processes in inpatient and ambulatory settings and the role of the pharmacist in this endeavor.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Merck puts $1.3bn into AI via Exscientia, BenevolentAI deals
pharmaphorum
SEPTEMBER 20, 2023
Merck puts $1.3bn into AI via Exscientia, BenevolentAI deals Phil.
Traditional Medicare lags behind MA, commercial plans in utilization, efficacy: research
Fierce Healthcare
SEPTEMBER 20, 2023
Traditional Medicare not only doesn’t measure up to Medicare Advantage (MA) when it comes to cutting back on utilization, it also falls short in many ways compared to commercial insurance for those | Researchers say Medicare Advantage enrollees have more than 50% fewer inpatient hospital stays than FFS Medicare enrollees and 22% fewer visits to emergency departments.
Tenth Circuit Decision Invalidates Oklahoma PBM Rules
Pharmacy Times
SEPTEMBER 20, 2023
Despite this decision, the trend of various states attempting to regulate pharmacy benefit managers is expected to continue
Lawmakers, payers and providers all air grievances with federal No Surprises Act implementation
Fierce Healthcare
SEPTEMBER 20, 2023
Amid a flurry of partisan roadblocks rolling out across Capitol Hill, representatives on both sides of the aisle came together Tuesday to critique federal agencies’ rollout of the No Surprises Act | Members of the House's Ways and Means Committee were unified in their critiques of HHS' "flawed implementation" of their bipartisan consumer protection legislation.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro
STAT
SEPTEMBER 20, 2023
As the gold rush over weight-loss drugs accelerates, Eli Lilly filed lawsuits against several compounding pharmacies, spas and wellness centers around the U.S. for selling unapproved versions of its Mounjaro diabetes drug, which is frequently used for combating obesity. The drug company accused four compound pharmacies of violating state laws because those versions were not approved by the U.S.
Transparent PBMs form coalition to advance industry reforms
Fierce Healthcare
SEPTEMBER 20, 2023
As pharmacy benefit managers and drug manufacturers once again sparred on the Hill, a group of transparent PBMs revealed that they had come together to form a coalition that drives industry reform. | As pharmacy benefit managers and drug manufacturers once again sparred on the Hill, a group of transparent PBMs revealed they had come together to form a coalition that drives industry reform.
ADDF invest in BrainScope for Alzheimer’s prediction biomarker
Pharmaceutical Technology
SEPTEMBER 20, 2023
The neurotech will receive the investment in Series B equity financing round to invest in Alzheimer’s disease research.
STAT+: How a cash-prize system that phases out patents may lower drug prices
STAT
SEPTEMBER 20, 2023
T wo months ago, Sen. Bernie Sanders (I-Vt.) moved a step closer to an idea he has championed for some time — awarding prizes, instead of patents, for inventing medicines. A measure was passed directing the National Academies of Sciences, Engineering, and Medicine to study the idea and was added to the Pandemic and All-Hazards Preparedness Act.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Hospital, ED staffer American Physician Partners files for Chapter 11 bankruptcy
Fierce Healthcare
SEPTEMBER 20, 2023
American Physician Partners, a Brentwood, Tennessee-based hospital staffing firm, announced Tuesday that it and its affiliates have filed for Chapter 11 bankruptcy protections “to complete the orde | The company said it has wound down over 150 contracts in July and attributed its financial difficulties to the pandemic and the No Surprises Act.
Opinion: Value-based payments are making it harder to see your primary care doctor on short notice
STAT
SEPTEMBER 20, 2023
Difficulty scheduling an urgent or time-sensitive appointment is now the most common gripe my patients sound off about to my primary care colleagues and me. Our practice is not the exception — it has become the rule. A 2022 national survey showed that, on average, it takes 20.6 days to get a family medicine appointment. There are many reasons for this, including, most significantly, a shorthanded clinician workforce, with many physicians either leaving primary care or opting for models li
CardioOne picks up seed funding, inks new partnerships with independent cardiology practices
Fierce Healthcare
SEPTEMBER 20, 2023
Cardiologists running independent practices face an increasingly complex operating environment with new payment models, fragmented technology, resource shortages and administrative burnout. | CardioOne is a care delivery enablement platform that works with independent cardiology practices to help them shift to value-based care. The startup inked new partnerships and nabbed $8 million in seed funding to fuel its growth.
Weed smokers often can’t work for the government. Some Republicans want to keep it that way
STAT
SEPTEMBER 20, 2023
WASHINGTON — Roughly three-quarters of states have legalized marijuana either for medical or recreational use, but for years, cannabis users have been barred from getting jobs with the federal government. Congress inched closer Wednesday toward making it easier for those who smoke pot to become feds, but several Republicans used the moment to rail against the idea.
Halloween spending set to reach $12.2B high
Drug Store News
SEPTEMBER 20, 2023
Total Halloween spending is expected to reach a record $12.2 billion, topping last year’s record of $10.6 billion and also exceeding pre-pandemic levels.
FDA asks for more data before considering needle-free anaphylaxis treatment
STAT
SEPTEMBER 20, 2023
ARS Pharma had high hopes that the FDA on Tuesday would approve its flagship product, a needle-free treatment for adults and children with severe allergic reactions. But instead, the drugmaker was set back with the agency requesting an additional study. Neffy, as the product is called, is a nasal spray that delivers the same drug, epinephrine, as the auto-injectors currently used to treat anaphylaxis.
Nordic Naturals to debut Omega-3 supplements at Sam’s Club in October
Drug Store News
SEPTEMBER 20, 2023
The partnership will offer exclusive bulk sizes of two of Nordic Naturals’ omega-3 supplements.
STAT+: The Apellis eye drug rebound accelerates. This time, it’s a competitor falling behind
STAT
SEPTEMBER 20, 2023
Apellis Pharmaceuticals has been slowly rebounding from an unjustified safety scare related to its approved treatment for a common type of vision loss. Now, a competing medicine from Astellas, also recently approved, may have stumbled, which could further boost Apellis’ business outlook — and its stock price. In a statement released Monday night, Astellas announced the “positive” outcome of an important follow-up analysis meant to demonstrate the two-year efficacy of
Walmart pilots Pet Services Center in Georgia
Drug Store News
SEPTEMBER 20, 2023
Located in Dallas, Ga., services will include routine veterinary care, grooming and a self-serve dog wash.
STAT+: Approval setback for EpiPen alternative puts spotlight on common anti-competition tactic
STAT
SEPTEMBER 20, 2023
Americans who suffer severe allergic reactions won’t have alternatives to autoinjectors like the Epipen for a while longer. In a surprise move, the Food and Drug Administration on Tuesday declined to approve neffy , an epinephrine nasal spray. Instead, the FDA asked the drug’s manufacturer, ARS Pharma, to conduct further studies, specifically comparing the effect of repeat doses of epinephrine administered via nasal spray versus auto-injection in people with allergic rhinitis, or h
Navigating the clean beauty maze
Drug Store News
SEPTEMBER 20, 2023
No matter how they define it, consumers want clean products. But is it enough to move the needle?
The evolution of computer validation from being on premises to being hosted in the cloud
pharmaphorum
SEPTEMBER 20, 2023
The evolution of computer validation from being on premises to being hosted in the cloud Mike.
The Global Vaccine R&D Pipeline and Delivery Implications
PharmExec
SEPTEMBER 20, 2023
The current vaccine pipeline brings promise of significant global health advancements—yet development gaps remain, and the future delivery challenges must be considered.
Hy-Vee awards $50,000 in grants to local minority- and women-owned businesses
Drug Store News
SEPTEMBER 20, 2023
Fourteen companies from across the Midwest presented to a panel of judges and more than 200 event attendees at the Hy-Vee OpportUNITY Inclusive Business Summit.
Researchers use AI to measure recovery from treatment-resistant depression
STAT
SEPTEMBER 20, 2023
Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI , they say. In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electro
Let's personalize your content